Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-26 Sale | 2023-01-27 4:44 pm | Metacrine Inc. | MTCR | York Michael Chief Business Officer | 107,054 | $0.4141 | $44,331 | 103,499 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-02-27 Option Award | 2022-03-01 4:55 pm | N/A 2032-02-26 | Metacrine Inc. | MTCR | York Michael Chief Business Officer | 210,553 | $0 | 421,106 (Direct) | View |
Ownership | 2022-02-24 4:52 pm | N/A 2031-11-30 | Metacrine Inc. | MTCR | York Michael Chief Business Officer | 0 | $0 | 235,000 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-24 6:10 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | York Michael VP, Corporate Development | 2,897 | $2.8 | 7,059 (Direct) | View |
| 2021-02-05 Option Award | 2021-02-09 4:52 pm | N/A 2031-02-05 | PhaseBio Pharmaceuticals Inc | PHAS | York Michael VP, Corporate Development | 36,000 | $0 | 36,000 (Direct) | View |
| 2020-11-20 Option Award | 2020-11-23 6:40 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | York Michael VP, Corporate Development | 2,662 | $3 | 4,162 (Direct) | View |
| 2020-02-12 Option Award | 2020-02-14 6:49 pm | N/A 2030-02-12 | PhaseBio Pharmaceuticals Inc | PHAS | York Michael VP, Corporate Development | 55,000 | $0 | 55,000 (Direct) | View |